PDS Biotechnology
PDSB
39 hedge funds and large institutions have $158M invested in PDS Biotechnology in 2015 Q4 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$46.8M |
| 2 |
NLVP
New Leaf Venture Partners
New York
|
+$37.8M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$37M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$14.2M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$11.4M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TA
26
Teachers Advisors
New York
| $106K | +$136K | +423 | New |
|
|
NFA
27
Nationwide Fund Advisors
Columbus,
Ohio
| $63K | +$80.9K | +251 | New |
|
28
Morgan Stanley
New York
| $46K | +$58.7K | +182 | New |
|
|
BA
29
BlackRock Advisors
Wilmington,
Delaware
| $36K | +$46.7K | +145 | New |
|
|
SO
30
STRS Ohio
Columbus,
Ohio
| $33K | +$43.5K | +135 | New |
|
31
Citigroup
New York
| $32K | +$40.9K | +127 | New |
|
32
Wells Fargo
San Francisco,
California
| $30K | +$39.3K | +122 | New |
|
33
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $26K | +$34.2K | +106 | New |
|
34
UBS Group
Zurich,
Switzerland
| $21K | +$27.7K | +86 | New |
|
35
BNP Paribas Financial Markets
Paris,
France
| $18.9K | +$24.5K | +76 | New |
|
36
Royal Bank of Canada
Toronto,
Ontario, Canada
| $13K | +$16.1K | +50 | New |
|
|
TRCT
37
Tower Research Capital (TRC)
New York
| $6K | +$8.38K | +26 | New |
|
38
Bank of America
Charlotte,
North Carolina
| $3K | +$3.22K | +10 | New |
|
39
Barclays
London,
United Kingdom
| $1K | +$1.93K | +6 | New |
|
PDSB Hedge Fund Activity: Q4 2015 in Review
39 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q4 2015, worth a combined $158M.
Buyers outnumbered sellers: 39 funds opened new PDSB positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $46.8M.
- 39 institutional investors held PDS Biotechnology (PDSB) as of Q4 2015, up from 0 in Q3 2015.
- Funds reported $158M of PDS Biotechnology stock for Q4 2015.
- 39 funds opened new PDS Biotechnology positions in Q4 2015 and 0 closed out, a net change of +39 holders.
- The largest PDS Biotechnology buyer in Q4 2015 was Fidelity Investments, an estimated $46.8M added.
Based on aggregated 13F filings for Q4 2015.